DMAC vs MLM · $157.4M cap vs P/E 36, rev $6.15B
DiaMedica Therapeutics Inc (DMAC) versus Martin Marietta Materials Inc (MLM) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Martin Marietta Materials Inc (MLM) is a building materials company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported MLM revenue for 2025-12-31 was $6.15B. Net income was $1.14B. Revenue was down 5.9% from 2024-12-31 to 2025-12-31. MLM currently screens at market cap $34.63B and trailing P/E 36.2.
DMAC currently screens at market cap $157.4M. MLM currently screens at market cap $34.63B and trailing P/E 36.2.
Not investment advice. Open the DMAC and MLM stock pages for the full models.
Not investment advice.